Literature DB >> 2904298

Antagonistic effects of alpha-adrenoceptor blocking agents on reticuloruminal hypomotility induced by xylazine in cattle.

Y Hikasa1, K Takase, S Emi, S Ogasawara.   

Abstract

The intravenous injection of a standard dose (0.05 mg/kg) of xylazine inhibited reticuloruminal motility in cattle. Pretreatment with adrenoceptor antagonists showing alpha 2-blocking activity, tolazoline (0.5 mg/kg) and yohimbine (0.2 mg/kg), antagonized the xylazine-induced reticuloruminal amotility. Tolazoline was more effective than yohimbine, since an antagonistic effect was not seen at 0.5 mg/kg yohimbine, and yohimbine at 0.2 mg/kg was less effective than tolazoline at 0.5 mg/kg. An adrenoceptor antagonist showing alpha 1-blocking activity, prazosin, did not prevent the inhibition of reticuloruminal motility by xylazine. The xylazine-induced reticuloruminal amotility was also not prevented by either a dopamine receptor antagonist, domperidone, or an opiate receptor antagonist, naloxone. These results suggest that xylazine inhibits bovine reticuloruminal motility through its activation of alpha 2-adrenoceptors, and show that tolazoline can be used as a specific antagonist of xylazine in studies of the alpha-adrenergic influence on reticuloruminal motility in cattle.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904298      PMCID: PMC1255482     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  28 in total

1.  Pharmacological characterisation of the presynaptic alpha-adrenoceptor in the rat vas deferens.

Authors:  G M Drew
Journal:  Eur J Pharmacol       Date:  1977-03-21       Impact factor: 4.432

Review 2.  Alpha-adrenergic receptor subtypes.

Authors:  B B Hoffman; R J Lefkowitz
Journal:  N Engl J Med       Date:  1980-06-19       Impact factor: 91.245

3.  Pharmacological classification of adrenergic alpha receptors in the guinea pig.

Authors:  J E Wikberg
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

4.  The locations and activities of medullary neurons associated with ruminant forestomach motility.

Authors:  R Harding; B F Leek
Journal:  J Physiol       Date:  1971-12       Impact factor: 5.182

5.  Xylazine-induced depression and its antagonism by alpha adrenergic blocking agents.

Authors:  W H Hsu
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

Review 6.  Role of phosphatidylinositol turnover in alpha 1 and of adenylate cyclase inhibition in alpha 2 effects of catecholamines.

Authors:  J N Fain; J A García-Sáinz
Journal:  Life Sci       Date:  1980-04-14       Impact factor: 5.037

7.  Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity.

Authors:  P M Laduron; J E Leysen
Journal:  Biochem Pharmacol       Date:  1979-07-15       Impact factor: 5.858

8.  Depression of reticulo-ruminal motor functions through the stimulation of alpha 2-adrenoceptors.

Authors:  Y Ruckebusch; C Allal
Journal:  J Vet Pharmacol Ther       Date:  1987-03       Impact factor: 1.786

9.  Functional characterization of central alpha-adrenoceptors by yohimbine diastereomers.

Authors:  L Hedler; G Stamm; R Weitzell; K Starke
Journal:  Eur J Pharmacol       Date:  1981-03-05       Impact factor: 4.432

10.  Xylazine-induced hyperglycemia in cattle: a possible involvement of alpha 2-adrenergic receptors regulating insulin release.

Authors:  W H Hsu; S K Hummel
Journal:  Endocrinology       Date:  1981-09       Impact factor: 4.736

View more
  2 in total

1.  Comparison of Atipamezole with Yohimbine for Antagonism of Xylazine in Mice Anesthetized with Ketamine and Xylazine.

Authors:  Christopher F Janssen; Pauline Maiello; M Jerry Wright; Kara B Kracinovsky; Joseph T Newsome
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-03-01       Impact factor: 1.232

2.  Comparative cardiopulmonary effects of carfentanil-xylazine and medetomidine-ketamine used for immobilization of mule deer and mule deer/white-tailed deer hybrids.

Authors:  N A Caulkett; P H Cribb; J C Haigh
Journal:  Can J Vet Res       Date:  2000-01       Impact factor: 1.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.